Stimulation of corticosterone and β-endorphin secretion in the rat by selective 5-HT receptor subtype activation

https://doi.org/10.1016/0014-2999(87)90175-0Get rights and content

Abstract

Changes in plasma concentrations of corticosterone and β-endorphin (β-END) were determined in male rats after treatment with the selective 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) or the non-selective 5-HT agonist 6-chloro-2-(1-piperazinyl)pyrazine (MK-212). The administration of either 8-OH-DPAT or MK-212 increased plasma concentrations of both corticosterone and β-END in a dose-related manner. The corticosterone and β-END responses to 8-OH-DPAT were antagonized by spiperone and (−)-pindolol, both of which have been shown to have high affinity for the 5-HT1A binding site. In contrast, antagonists which are selective for the 5-HT2 receptor or non-selective 5-HT antagonists were without effect on the hormone responses to 8-OH-DPAT. The MK-212-induced increase in plasma concentrations of corticosterone and β-END were not affected by treatment with the 5-HT1A antagonists spiperone and (−)-pindolol. However, the corticosterone and β-END responses to MK-212 were attenuated by the selective 5-HT2 antagonists ketanserin, ritanserin and altanserin, as well as by the non-selective 5-HT antagonist metergoline. It is concluded that stimulation of either 5-HT1A or 5-HT2 receptors results in an activation of the hypothalamic-pituitary-adrenal axis in the rat.

References (39)

  • M.D. Tricklebank et al.

    Subtypes of the 5-HT receptor mediating the behavioral responses to 5-methoxy-N,N-dimethyltryptamine in the rat

    European J. Pharmacol.

    (1985)
  • C.Y. Yap et al.

    Involvement of 5-HT2 receptors in the wet dog shake behavior induced by 5-hydroxytryptophan in the rat

    Neuropharmacology

    (1983)
  • F.C. Colpaert et al.

    Behavioral and 5-HT antagonist effects of ritanserin: A pure and selective antagonist of LSD discrimination in rat

    Psychopharmacology

    (1985)
  • G. Engel et al.

    Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites

    Naunyn Schmiedeb. Arch. Pharmacol.

    (1986)
  • R.W. Fuller

    Drugs influencing serotonergic neurotransmission

  • R.W. Fuller

    Serotonergic stimulation of pituitary-adrenocortical function in rats

    Neuroendocrinology

    (1981)
  • R.W. Fuller et al.

    Central serotonin antagonist activity of ketanserin

    Res. Commun. Chem. Path. Pharmacol.

    (1984)
  • G.M. Goodwin et al.

    A behavioral and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors

    Br. J. Pharmacol.

    (1985)
  • H. Gozlan et al.

    Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-DPAT

    Nature

    (1983)
  • Cited by (193)

    • Autophagy inhibition plays a protective role against 3, 4-methylenedioxymethamphetamine (MDMA)-induced loss of serotonin transporters and depressive-like behaviors in rats

      2019, Pharmacological Research
      Citation Excerpt :

      Further studies are necessary to elucidate the actual mechanism by which MDMA induces low density of SERT. MDMA has been well demonstrated to induce an immediate elevation in plasma corticosterone or cortisol level [26,27,43,44], likely resulting from the release of 5-HT and activation of 5-HT2 receptor on hypothalamic neurons that regulate pituitary-adrenocortical function [45–47]. In agreement with previous studies, our results revealed that MDMA induced significant increase in plasma concentration of corticosterone.

    • Evaluation of brain SERT occupancy by resveratrol against MDMA-induced neurobiological and behavioral changes in rats: A 4-[<sup>18</sup>F]-ADAM/small-animal PET study

      2016, European Neuropsychopharmacology
      Citation Excerpt :

      However, our data showed that RSV afforded negligible protection against MDMA-induced loss of SERT in the frontal cortex (Figure 4B). MDMA has been well demonstrated to induce an immediate elevation in plasma corticosterone or cortisol level (Downey et al., 2015; Johnson and Yamamoto, 2010; Parrott et al., 2013; Parrott et al., 2014), likely resulting from the release of 5-HT and activation of 5-HT2 receptor on hypothalamic neurons that regulate pituitary-adrenocortical function (Fuller, 1981; Holmes et al., 1982; Koenig et al., 1987). The current data confirmed these previous findings (Figure 3C), although this MDMA-induced effect was ceased upon drug withdrawn.

    • Chronic unpredictable stress augments +3,4-methylenedioxymethamphetamine-induced monoamine depletions: The role of corticosterone

      2009, Neuroscience
      Citation Excerpt :

      Therefore, the enhancement of MDMA-induced hyperthermia after CUS may be mediated by a chronic stress-induced and CORT-dependent increase in 5-HT2A receptor density or function. Hypothalamic 5-HT2A receptors are also involved in for CORT regulation (Koenig et al., 1987), although we found enhanced MDMA-induced hyperthermia without a potentiation of CORT. This may be the result of a differential regulation of hyperthermia and CORT by 5HT2A receptors in subregions of the hypothalamus.

    • Interaction between serotonin 5-HT1A receptors and β-endorphins modulates antidepressant response

      2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry
    View all citing articles on Scopus
    1

    Present address: Neurology Service, Massachusetts General Hospital, 34 Fruit Street, Boston, MA 02114, U.S.A.

    View full text